Evolv Technologies director granted 3,731 RSUs
Evolv Technologies Holdings, Inc. reported that director Mark J. Sullivan received a grant of 3,731 Restricted Stock Units (RSUs) on January 2, 2026.
Rhea-AI Filing Summary
Evolv Technologies Holdings, Inc. reported that director Mark J. Sullivan received a grant of 3,731 Restricted Stock Units (RSUs) on January 2, 2026. Each RSU represents a contingent right to receive one share of the company’s Class A common stock at no purchase price, and the RSUs have no expiration date.
The filing states that these 3,731 RSUs will vest in full on December 31, 2026, after which they can settle into an equal number of Class A common shares, assuming vesting conditions are met. Following this award, Sullivan beneficially owns 3,731 RSUs directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 3,731 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.
- F2. The RSUs will vest in full on December 31, 2026.
FAQ
What insider transaction did Evolv Technologies Holdings (EVLV) report?
What does each RSU represent in the EVLV Form 4 filing?
When do Mark J. Sullivan’s 3,731 RSUs in EVLV vest?
How many Evolv Technologies RSUs does Mark J. Sullivan own after this transaction?
What was the price per RSU in the EVLV director grant?
Is the EVLV insider transaction a derivative or non-derivative security?
AI-generated analysis. How Rhea-AI works. Not financial advice.